Clonal evolution in patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 51, Issue 6, 2010, Pages 1142-1143

  Loscertales, Javier ^a   Arranz, Eva ^a   Sanz, Maria Angeles ^a   Blas, Carlos ^b   Gil Fernndez, Juan J ^c   Burgaleta, Carmen ^c   Alegre, Adrin ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Gemolab Laboratory   (Spain)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LYMPHATIC LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; LETTER; PRIORITY JOURNAL; TRISOMY; ADULT; AGED; CELL CLONE; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME DELETION; CLINICAL TRIAL; FEMALE; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN VARIABLE REGION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CLONE CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES;

EID: 77953528163     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003793374     Document Type: Letter

References (8)

1. Chevallier P, Penther D, Avet-Loiseau H, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002;116:142-150.
2. Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24:4634-4641.
3. Stilgenbauer S, Sander S, Bullinger L, et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 2007;92:1242-1245.
4. Berkova A, Zemanova Z, Trneny M, et al. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma 2009;56:455-458.
5. Malcikova J, Smardova J, Rocnova L, et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival and response to DNA damage. Blood 2009;114:5307-5314.
6. Bagnara D, Callea V, Stelitano C, et al. IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukaemia. Br J Haematol 2006;133:50-58.
7. Chena C, Avalos JS, Bezares RF, et al. Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: cytogenetic, FISH and clinical studies. Eur J Haematol 2008;81:94-99.
8. Zenz T, Häbe S, Denzel T, et al. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood 2009;114:2589-2597.